Abstract
A Caucasian female, 36-year-old, became unwell and jaundiced over a period of 2 weeks. Her bilirubin was 400 μmol/l; AST 848 iu/l; INR 2.99 (norm. 0.9–1.2). Plasma ammonium ranged between 115 and 185 μmol/l (normal, <40 μmol/l). Three days later (day 0), she received right liver lobe auxiliary transplant from a cadaveric donor. On day 8, she was discharged from intensive care unit; her hemoglobin was 8.2 g/dl, and the bilirubin 162 μmol/l. On day 10, bilirubin was 294 μmol/l; hemoglobin decreased to 6.1 g/l, without signs of acute hemorrhage. The ward staff requested two units of red cells.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Mijovic A, Abdallah A, Pearce L, et al. Effects on erythropoiesis of alemtuzumab-containing reduced intensity and standard conditioning regimes. Br J Haematol. 2008;142:444–52.
Ramsey G. Red cell antibodies arising after solid organ transplants. Transfusion. 1991;31:76–86.
Further Reading
Petz LD, Garratty G. Immune haemolytic anaemias. 2nd ed. Philadelphia: Churchill Livingstone; 2004.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag London Limited
About this chapter
Cite this chapter
Mijovic, A. (2012). An Unwanted Passenger. In: Transfusion Medicine. Springer, London. https://doi.org/10.1007/978-1-4471-2182-4_5
Download citation
DOI: https://doi.org/10.1007/978-1-4471-2182-4_5
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-2181-7
Online ISBN: 978-1-4471-2182-4
eBook Packages: MedicineMedicine (R0)